Merck & Co., Inc. is a global research-driven pharmaceutical company dedicated to putting patients first.

A Summary of Merck’s HIV and AIDS Partnerships and Programs

Advancing the Dialogue Toward a Healthier Future

Overview Global Africa Europe Asia Pacific Americas

Improving access requires more than simply making our medicines available and affordable. The most important factors for long-term sustainability are strengthening health care infrastructure, ensuring adequate financing for health, and helping to build local health care capacity through training and support.

Public/private partnerships have a critical role to play in this process, drawing on the complementary expertise of all stakeholders — governments, international agencies, community organizations, donors, the private sector, nongovernmental organizations, patients and others — to identify the most promising and efficient ways to address the impact of HIV and AIDS in a variety of resource-scarce settings.

In this section are examples of some of the many programs and partnerships Merck supports around the world to help address the challenge of HIV and AIDS.

The content on this page was last modified on September 15, 2009.

Merck & Co., Inc., Whitehouse Station, NJ, USA, and Schering-Plough Corporation, Kenilworth, NJ, USA, are now one company. We have combined our global operations under the name Merck & Co., Inc. We are working to update our corporate responsibility Web site to reflect our new, combined, global organization.

Copyright © 2009 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Whitehouse Station, N.J., U.S.A.  Privacy  Terms of Use  Sitemap